|
|
|||
| |||||||||||||||||||||||||||||||||||||
This second edition of Pulmonary Circulation is timely. Nine years have elapsed since its first edition in 1996, years in which we have witnessed such major scientific advances as the description of the human genome (2001) and, directly relevant to the pulmonary circulation, alteration of the gene for bone morphogenetic protein receptor type 2 (BMPR2) on chromosome 2q33. Two groups of investigators identified BMPR2 mutations in about 50 percent of familial cases and 26 percent of sporadic cases of idiopathic pulmonary arterial hypertension at the midpoint (2000) between publication of the first and second editions of Pulmonary
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |